Blood Test, Colorectal cancer

Accurate New Blood Test for Colon Cancer
An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.
A new blood test accurately screens for colorectal cancer, researchers say
Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer in people who had the disease. The test is 90% accurate in ruling out cancer in healthy adults, according to the study published Monday in the Journal of Clinical Oncology.
Blood test accurately detects colon cancer
An experimental blood test can effectively and accurately detect colon cancer in middle-aged folks and seniors, a new study says. The research is published in the Journal of Clinical Oncology.
Promising New Blood Test for Colorectal Cancer Screening
A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.
New colorectal cancer prediction test is more than 90% accurate
A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the five years. People with inflammatory bowel disease — which includes conditions like ulcerative colitis and Crohn’s — are up to four times more likely to get this type of cancer,
Blood Test Can Detect Colorectal Cancer in Average-Risk Individuals
An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.
Breakthrough blood test shows high accuracy in detecting colon cancer
A simple blood test has shown promising results in accurately detecting colon cancer, a deadly disease that is rising at an alarming rate, especially among young adults. The experimental test not only identifies colon cancer effectively but also rules it out in
Blood-based test could increase adherence to colorectal cancer screening
An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.
Blood Test May Guide Anti-Inflammatory Drug Use To Reduce Colon Cancer Risk
A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after ...
New bowel cancer test has ‘90% accuracy’ at predicting disease in those at high risk – without invasive procedures
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
Guardant Health’s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced an agreement with the Abu Dhabi ...
Medical Xpress4d
Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence
Evidence has since emerged suggesting that anti-inflammatory drugs might benefit some patients with colon cancer, but not others. One possibility for this is that patients who have a blood ...